Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson’s Disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson’s Disease?

Published:2018-07-19 Issue:10 Volume:32 Page:971-979
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Chung Seok Jong,Yoo Han Soo,Lee Hye Sun,Jeong Hyo Eun,Kim Soo-Jong,Oh Jungsu S.,Kim Jae Seung,Sohn Young H.,Lee Phil Hyu

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

http://link.springer.com/article/10.1007/s40263-018-0549-x/fulltext.html

Reference30 articles.

1. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–601. https://doi.org/10.1002/mds.26424 .

2. Jenner P. Preventing and controlling dyskinesia in Parkinson’s disease: a view of current knowledge and future opportunities. Mov Disord. 2008;23(Suppl. 3):S585–98. https://doi.org/10.1002/mds.22022 .

3. Sharma JC, Bachmann CG, Linazasoro G. Classifying risk factors for dyskinesia in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(8):490–7. https://doi.org/10.1016/j.parkreldis.2010.06.003 .

4. Chase TN. Levodopa therapy: consequences of the nonphysiologic replacement of dopamine. Neurology. 1998;50(5 Suppl. 5):S17–25.

5. Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci. 2001;2(8):577–88. https://doi.org/10.1038/35086062 .

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta‐Analysis;Movement Disorders Clinical Practice;2024-08-27

2. Levodopa versus levodopa sparing in early parkinson�s disease: can we meet halfway?;Revista de investigaci�n Cl�nica;2024-07-12

3. Tiempo hasta la modificación de la terapia antiparkinsoniana en un grupo de pacientes de Colombia;Revista de Neurología;2023

4. Real World Pharmacological First Treatment Patterns of Patients With Parkinson Disease and Disease Duration;Clinical Neuropharmacology;2021-06-26

5. Paeoniflorin and Plycyrrhetinic Acid Synergistically Alleviate MPP+/MPTP-Induced Oxidative Stress through Nrf2-Dependent Glutathione Biosynthesis Mechanisms;ACS Chemical Neuroscience;2021-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3